Published in Volume
118, Issue 8 (August 1, 2008)
J Clin Invest. 2008;118(8):2986–2986.
doi:10.1172/JCI33637C1.
Copyright © 2008, American Society for Clinical Investigation
Corrigendum
Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells
Hewang Li, Ines Armando, Peiying Yu, Crisanto Escano, Susette C. Mueller, Laureano Asico, Annabelle Pascua, Quansheng Lu, Xiaoyan Wang, Van Anthony M. Villar, John E. Jones, Zheng Wang, Ammasi Periasamy, Yuen-Sum Lau, Patricio Soares-da-Silva, Karen Creswell, Gaétan Guillemette, David R. Sibley, Gilbert Eisner, John J. Gildea, Robin A. Felder and Pedro A. Jose
Published August 1, 2008
Original citation: J. Clin. Invest.
118:2180-2189 (2008). doi:10.1172/JCI33637.
Citation for this corrigendum: J. Clin. Invest. 118:2986 (2008). doi:10.1172/JCI33637C1.
During the preparation of the manuscript, John J. Gildea’s name was inadvertently omitted from the author list. Gildea is affiliated with the Department of Pathology, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA. The correct author list appears above.
The authors regret the error.
